Europass Curriculum Vitae - Farmacia e Medicina
Transcript
Europass Curriculum Vitae - Farmacia e Medicina
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) Marco Cippitelli Dpt. of Molecular Medicine, University of Rome “La Sapienza”, Via Regina Elena, 291, 00161, Rome, Italy. Telephone(s) +0039 0649255152 Fax(es) +0039 0644340632 E-mail Nationality Date of birth Gender Mobile: [email protected] or [email protected] Italian 31-10-1964 Male Occupational field Teaching and research. Page 1/5 - Curriculum vitae of Surname(s) First name(s) For more information on Europass go to http://europass.cedefop.europa.eu © European Union, 2004-2010 24082010 Work experience 2007/Present: - Study of the molecular mechanisms that regulate the transcription, expression and function of NK cell-activating ligands by different chemoterapics, in cancer cells. 2005/2007: - Study of the molecular mechanisms that modulate the transcription and function of the Rank-L and Trail genes by nuclear receptors and specific ligands in activated T cells: modulation mediated by activators of the PPAR-gamma. 2003/2005: - Study of the molecular mechanisms mediated by hyperthermia, that enhance the transcription of the FasL gene in activated T cells. 2000/2003: - Study of the molecular mechanisms that modulate the transcription and function of the FasL gene by different nuclear receptors and specific ligands in activated T cells: modulation mediated by Calcitriol (Vitamin-D3)/VDR, and by activators of the PPAR-gamma. - Study of the anti-apoptotic protein Bcl-2, as a molecule able to regulate NFkB transcriptional activity and MMP-9 metallo-proteinase gene expression, in human breast carcinoma cells. - Study of the signaling pathways involved in the activation of the IFN-gamma gene, mediated by integrin receptors, in NK cells. 1996/98: - Study of the molecular mechanisms that modulate the transcription of the IFN-gamma and IL-12 genes, activated by the nuclear receptor VDR (vitamin D3/R) in T cells and monocytes/dendritic cells. 1992/95: - Study of the transcriptional events that regulate IFN-gamma, IL-2 and IL-4 genes in activated T cells. Analisys of the role of AP1/CREB-ATF, NF-AT, NF-kB transcription factors involved in these events. These studies have given important contributions to understand the intracellular pathways that regulate these genes in T cells. Occupation or position held 2007-date Associate Professor General Pathology/Immunology Main activities and responsibilities Teaching and Research. Name and address of employer Sector Page 2/5 - Curriculum vitae of Surname(s) First name(s) University of Rome “La Sapienza”, Rome, Italy Dpt. of Molecular Medicine, University of Rome “La Sapienza”, Via Regina Elena, 291, 00161, Rome, Italy Med-04 For more information on Europass go to http://europass.cedefop.europa.eu © European Union, 2004-2010 24082010 Education and training Dates 2007-Present. Associate Professor - General Pathology (Med-04), Dept. of Molecular Medicine, University of Rome "La Sapienza". 2000-2007. Research Associate - General Pathology (Med-04), Dept. of Experimental Medicine and Pathology, University of Rome "La Sapienza". 1996-2000. Research Scientist at the Laboratory of Immunology (Dept. Experimental Medicine and Pathology) and Laboratory of Pathophysiology, CRS, Regina Elena, Rome. 1996. PhD University of Rome "La Sapienza". 1992-1995. Visiting Scientist at the "Biological Carcinogenesis and Development Program, “Molecular Immunology Section" (Laboratory of Experimental Immunology) National Cancer Institute (NCI) Frederick, Maryland, USA. 1990. Graduated in Biological Science (summa cum laude), University of Rome "La Sapienza". Personal skills and competences Immunology, Molecular biology, Transcriptional regulation. Mother tongue(s) Other language(s) Self-assessment Specify mother tongue Italian. English Understanding Speaking European level (*) Listening Reading Language C1 C1 Spoken interaction Writing Spoken production C1 B2 B2 Language (*) Common European Framework of Reference for Languages Additional information Include here any other information that may be relevant, for example contact persons, references, etc. Recieving Fundings Page 3/5 - Curriculum vitae of Surname(s) First name(s) Every day, previous appointment. 2001-2002 – Grant Ministero Sanità- Finalizzata/Conv. IFO, Roma. 2005/2007 - Ricerche di Facoltà (ex 60%) 2007/2009 - Ricerca di Ateneo Federato 2009 – Ricerca di Ateneo Federato 2011 - FARI, Ricerche Universitarie "Sapienza". 2011/2013 - Progetto di ricerca scientifica approvato dalla Regione Lazio/Sapienza. PRIN Grant 2006 PRIN Grant 2008 PRIN Grant 2010/2011 For more information on Europass go to http://europass.cedefop.europa.eu © European Union, 2004-2010 24082010 Selected Scientific Publications 1) Ricca A., Biroccio A., Del Bufalo D., Mackay AR., Santoni A., and Cippitelli M. Bcl-2 overexpression enhances NF-kB activity and induces MMP-9 transcription in human MCF7ADR breast cancer cells. INT. J. CANCER. (2000) 86, 188 IF: 5.007 2) Ricca A., Biroccio A., Trisciuoglio D., Cippitelli M. and Del Bufalo D. RelA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. BR. J. CANCER. (2001) 85(12), 1914 IF: 4.817 3) Cippitelli M., Fionda C., Di Bona D., Di Rosa F., Lupo A., Piccoli M., Frati L. and Santoni A. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. J. IMMUNOL. (2002) 168(3), 1154. IF: 5.362 4) Cippitelli M., Fionda C., Di Bona D., Lupo A., Piccoli M., Frati L. and Santoni A. The cyclopentenone-type prostaglandin 15-deoxy-delta12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. J. IMMUNOL. (2003) 170(9), 4578. IF: 5.362 5) Cippitelli M., Fionda C., Di Bona D., Piccoli M., Frati L. and Santoni A. Hyperthermia enhances CD95Ligand gene expression in T lymphocytes. J. IMMUNOL. (2005) 174(1), 223. IF: 5.362 6) Di Bona D., Cippitelli M., Fionda C., Camma C., Licata A., Santoni A., Craxi A. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J. HEPATOL. (2006) 45(2), 271. IF: 9.557 7) Fionda C., Nappi F., Piccoli M., Frati L., Santoni A. and Cippitelli M. 15-deoxy-12,14-Prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: Role of NF-kB and Early Growth Response transcription factors. J. IMMUNOL. (2007) 178(7):4039-50 IF: 5.362 8) Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATRdependent mechanism and become susceptible to autologous NK- cell lysis. BLOOD. (2007) Jul 15;110(2):606-15. IF: 9.775 9) Fionda C., Nappi F., Piccoli M., Frati L., Santoni A. and Cippitelli M. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. MOL PHARMACOL. (2007) Nov;72(5):1246-57. IF: 4.120 10) Soriani A., Zingoni A., Cerboni C., Iannitto ML., Ricciardi MR., Di Gialleonardo V., Cippitelli M., Fionda C., Petrucci MT., Guarini A., Foa R., Santoni A. ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype. BLOOD. (2009) 113(15): 3503-3511. IF: 9.775 11) Nappi F., Chiozzini C., Bordignon V., Borsetti A., Bellino S., Cippitelli M., Barillari G., Caputo A., Tyagi M., Giacca M., Ensoli B. Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles. THE J. OF GENE MEDICINE. (2009) 11(11):955-965. IF: 1.953 Page 4/5 - Curriculum vitae of Surname(s) First name(s) For more information on Europass go to http://europass.cedefop.europa.eu © European Union, 2004-2010 24082010 12) Fionda C., Soriani A., Malgarini G., Iannitto ML., Santoni A., Cippitelli M. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. J. IMMUNOL. (2009) 183(7):4385-4394. IF: 5.362 13) Angela C. Quinci, Sara Vitale, Elisabetta Parretta, Alessandra Soriani, Maria Luisa Iannitto, Marco Cippitelli, Cinzia Fionda, Silvia Bulfone-Paus, Angela Santoni, Francesca Di Rosa (2012). IL-15 inhibits IL-7Rα expression by memory-phenotype CD8⁺ T cells in the bone marrow. EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 42, p. 1129-1139. IF: 4.518 14) Cinzia Fionda, Giulia Malgarini, Alessandra Soriani, Alessandra Zingoni, Francesca Cecere, Maria Luisa Iannitto, Maria Rosaria Ricciardi, V. Federico, Maria Teresa Petrucci, Angela Santoni, Marco Cippitelli (2013). Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3. JOURNAL OF IMMUNOLOGY, vol. 190, p. 6662-6672. IF: 5.362 15) Alessandra Soriani, Cinzia Fionda, Biancamaria Ricci, Maria Luisa Iannitto, Marco Cippitelli, Angela Santoni (2013). Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma. ONCOIMMUNOLOGY, vol. 2, p. e26663-1-e26663-3. IF: 6.283 16) Cristina Cerboni, Cinzia Fionda, Alessandra Soriani, Alessandra Zingoni, Margherita Doria, Marco Cippitelli, Angela Santoni (2014). The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells. FRONTIERS IN IMMUNOLOGY, vol. 4, p. art. 508-1-art. 508-7. 17) Alessandra Soriani, Maria Luisa Iannitto, Biancamaria Ricci, Cinzia Fionda, Giulia Malgarini, Stefania Morrone, Giovanna Peruzzi, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Marco Cippitelli, Angela Santoni (2014). Reactive Oxygen Species- and DNA Damage Response-Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1. JOURNAL OF IMMUNOLOGY, vol. 193, p. 950-960. IF: 5.362 18) D. Di Bona, V. Scafidi, A. Plaia, C. Colomba, D. Nuzzo, C. Occhino, A. Tuttolomondo, G. Giammanco, S. De Grazia, G. Montalto, G. Duro, Marco Cippitelli, C. Caruso (2014). HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection. THE JOURNAL OF INFECTIOUS DISEASES, vol. 210, p. 1083-1089. IF: 5.778 19) C. Fionda, MP. Abruzzese, A. Zingoni, A. Soriani, BM. Ricci, R. Molfetta, R. Paolini, A. Santoni and M. Cippitelli. (2015). Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation. BMC CANCER, vol. 15:17. IF: 3.319 20) Zingoni A, Cecere F, Vulpis E, Fionda C, Molfetta R, Soriani A, Petrucci MT, Ricciardi MR, Fuerst D, Amendola MG, Mytilineos J, Cerboni C, Paolini R, Cippitelli M, Santoni A. (2015) .Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells. J IMMUNOL. 2015 Jul 15;195(2):736-48. doi: 10.4049/jimmunol.1402643. IF: 5.362 21) Fionda C, Soriani A, Zingoni A, Santoni A, Cippitelli M. (2015). NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma. BIOMED RES INT. 2015;2015:178698. doi: 10.1155/2015/178698. Review. IF: 1.579 22) Fionda C, Abruzzese MP, Zingoni A, Cecere F, Vulpis E, Peruzzi G, Soriani A, Molfetta R, Paolini R, Ricciardi MR, Petrucci MT, Santoni A, Cippitelli M. (2015) The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma. ONCOTARGET. 2015 Sep 15;6(27):23609-30. IF: 6.359 23) Quatrini L, Molfetta R, Zitti B, Peruzzi G, Fionda C, Capuano C, Galandrini R, Cippitelli M, Santoni A, Paolini R. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells. (2015) SCI SIGNAL. 2015 Oct 27;8(400):ra108. IF: 6.279 Page 5/5 - Curriculum vitae of Surname(s) First name(s) For more information on Europass go to http://europass.cedefop.europa.eu © European Union, 2004-2010 24082010